ID   AL7A1_HUMAN             Reviewed;         539 AA.
AC   P49419; B2R669; B4DIC7; B4DMA0; E7EPT3; O14619; Q6IPU8; Q9BUL4;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 5.
DT   10-MAY-2017, entry version 179.
DE   RecName: Full=Alpha-aminoadipic semialdehyde dehydrogenase;
DE            Short=Alpha-AASA dehydrogenase;
DE            EC=1.2.1.31;
DE   AltName: Full=Aldehyde dehydrogenase family 7 member A1;
DE            EC=1.2.1.3;
DE   AltName: Full=Antiquitin-1;
DE   AltName: Full=Betaine aldehyde dehydrogenase;
DE            EC=1.2.1.8;
DE   AltName: Full=Delta1-piperideine-6-carboxylate dehydrogenase;
DE            Short=P6c dehydrogenase;
DE   Flags: Precursor;
GN   Name=ALDH7A1; Synonyms=ATQ1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney, Liver, and Placenta;
RX   PubMed=8088832; DOI=10.1006/geno.1994.1279;
RA   Lee P., Kuhl W., Gelbart T., Kamimura T., West C., Beutler E.;
RT   "Homology between a human protein and a protein of the green garden
RT   pea.";
RL   Genomics 21:371-378(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Brain, Caudate nucleus, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLN-439.
RC   TISSUE=Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 233-268, AND TISSUE SPECIFICITY.
RX   PubMed=9417906; DOI=10.1006/geno.1997.5026;
RA   Skvorak A.B., Robertson N.G., Yin Y., Weremowicz S., Her H.,
RA   Bieber F.R., Beisel K.W., Lynch E.D., Beier D.R., Morton C.C.;
RT   "An ancient conserved gene expressed in the human inner ear:
RT   identification, expression analysis, and chromosomal mapping of human
RT   and mouse antiquitin (ATQ1).";
RL   Genomics 46:191-199(1997).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2 (ISOFORM 2), CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2 (ISOFORM 2), CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 30-526, FUNCTION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ALTERNATIVE SPLICING, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=20207735; DOI=10.1074/jbc.M109.077925;
RA   Brocker C., Lassen N., Estey T., Pappa A., Cantore M., Orlova V.V.,
RA   Chavakis T., Kavanagh K.L., Oppermann U., Vasiliou V.;
RT   "Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in
RT   cellular defense against hyperosmotic stress.";
RL   J. Biol. Chem. 285:18452-18463(2010).
RN   [11]
RP   VARIANTS PDE VAL-199 AND GLN-427, AND FUNCTION.
RX   PubMed=16491085; DOI=10.1038/nm1366;
RA   Mills P.B., Struys E., Jakobs C., Plecko B., Baxter P.,
RA   Baumgartner M., Willemsen M.A.A.P., Omran H., Tacke U., Uhlenberg B.,
RA   Weschke B., Clayton P.T.;
RT   "Mutations in antiquitin in individuals with pyridoxine-dependent
RT   seizures.";
RL   Nat. Med. 12:307-309(2006).
RN   [12]
RP   VARIANTS PDE VAL-202; GLU-291; ILE-301; GLN-335; GLY-395; GLN-427 AND
RP   ASN-458.
RX   PubMed=17068770; DOI=10.1002/humu.20433;
RA   Plecko B., Paul K., Paschke E., Stoeckler-Ipsiroglu S., Struys E.,
RA   Jakobs C., Hartmann H., Luecke T., di Capua M., Korenke C., Hikel C.,
RA   Reutershahn E., Freilinger M., Baumeister F., Bosch F., Erwa W.;
RT   "Biochemical and molecular characterization of 18 patients with
RT   pyridoxine-dependent epilepsy and mutations of the antiquitin
RT   (ALDH7A1) gene.";
RL   Hum. Mutat. 28:19-26(2007).
CC   -!- FUNCTION: Multifunctional enzyme mediating important protective
CC       effects. Metabolizes betaine aldehyde to betaine, an important
CC       cellular osmolyte and methyl donor. Protects cells from oxidative
CC       stress by metabolizing a number of lipid peroxidation-derived
CC       aldehydes. Involved in lysine catabolism.
CC       {ECO:0000269|PubMed:16491085, ECO:0000269|PubMed:20207735}.
CC   -!- CATALYTIC ACTIVITY: (S)-2-amino-6-oxohexanoate + NAD(P)(+) + H(2)O
CC       = L-2-aminoadipate + NAD(P)H.
CC   -!- CATALYTIC ACTIVITY: Betaine aldehyde + NAD(+) + H(2)O = betaine +
CC       NADH.
CC   -!- CATALYTIC ACTIVITY: An aldehyde + NAD(+) + H(2)O = a carboxylate +
CC       NADH.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=28.5 uM for nonanal {ECO:0000269|PubMed:20207735};
CC         KM=5.3 uM for trans-2-nonenal {ECO:0000269|PubMed:20207735};
CC         KM=39.1 uM for hexanal {ECO:0000269|PubMed:20207735};
CC         KM=17.5 uM for octanal {ECO:0000269|PubMed:20207735};
CC         KM=41.1 uM for betaine aldehyde {ECO:0000269|PubMed:20207735};
CC         KM=169 uM for L-2-aminoadipate 6-semialdehyde
CC         {ECO:0000269|PubMed:20207735};
CC         KM=530.2 uM for benzaldehyde {ECO:0000269|PubMed:20207735};
CC         KM=647.4 uM for propanal {ECO:0000269|PubMed:20207735};
CC         KM=7374.3 uM for glyceraldehyde {ECO:0000269|PubMed:20207735};
CC         Vmax=364.9 nmol/min/mg enzyme toward nonanal
CC         {ECO:0000269|PubMed:20207735};
CC         Vmax=34.9 nmol/min/mg enzyme toward trans-2-nonenal
CC         {ECO:0000269|PubMed:20207735};
CC         Vmax=243.3 nmol/min/mg enzyme toward hexanal
CC         {ECO:0000269|PubMed:20207735};
CC         Vmax=72.3 nmol/min/mg enzyme toward octanal
CC         {ECO:0000269|PubMed:20207735};
CC         Vmax=101.4 nmol/min/mg enzyme toward betaine aldehyde
CC         {ECO:0000269|PubMed:20207735};
CC         Vmax=276.2 nmol/min/mg enzyme toward L-2-aminoadipate 6-
CC         semialdehyde {ECO:0000269|PubMed:20207735};
CC         Vmax=125.2 nmol/min/mg enzyme toward benzaldehyde
CC         {ECO:0000269|PubMed:20207735};
CC         Vmax=69.9 nmol/min/mg enzyme toward propanal
CC         {ECO:0000269|PubMed:20207735};
CC         Vmax=174 nmol/min/mg enzyme toward glyceraldehyde
CC         {ECO:0000269|PubMed:20207735};
CC   -!- PATHWAY: Amine and polyamine biosynthesis; betaine biosynthesis
CC       via choline pathway; betaine from betaine aldehyde: step 1/1.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q12929:EPS8; NbExp=2; IntAct=EBI-726842, EBI-375576;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:20207735}. Nucleus
CC       {ECO:0000269|PubMed:20207735}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Mitochondrion
CC       {ECO:0000269|PubMed:20207735}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=hALDH7A1_v1 {ECO:0000269|PubMed:20207735};
CC         IsoId=P49419-1; Sequence=Displayed;
CC       Name=2; Synonyms=hALDH7A1_v2 {ECO:0000269|PubMed:20207735};
CC         IsoId=P49419-2; Sequence=VSP_038987;
CC         Note=Initiator Met-1 is removed. Contains a N-acetylserine at
CC         position 2. {ECO:0000244|PubMed:19413330,
CC         ECO:0000244|PubMed:22223895};
CC       Name=4;
CC         IsoId=P49419-4; Sequence=VSP_045905;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Abundant in hepatoma cells and fetal cochlea,
CC       ovary, eye, heart, adrenal gland, liver and kidney. Low levels
CC       present in adult peripheral blood leukocytes and fetal brain,
CC       thymus, spleen, skeletal muscle, lung and tongue.
CC       {ECO:0000269|PubMed:8088832, ECO:0000269|PubMed:9417906}.
CC   -!- DISEASE: Pyridoxine-dependent epilepsy (PDE) [MIM:266100]:
CC       Characterized by a combination of various seizure types. It
CC       usually occurs in the first hours of life and is unresponsive to
CC       standard anticonvulsants, responding only to immediate
CC       administration of pyridoxine hydrochloride.
CC       {ECO:0000269|PubMed:16491085, ECO:0000269|PubMed:17068770}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC51935.1; Type=Frameshift; Positions=233, 268; Evidence={ECO:0000305};
CC       Sequence=AAH02515.3; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH71712.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH73174.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG35366.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG58439.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=BAG59812.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S74728; AAB31966.1; -; mRNA.
DR   EMBL; AK312459; BAG35366.1; ALT_INIT; mRNA.
DR   EMBL; AK295526; BAG58439.1; ALT_SEQ; mRNA.
DR   EMBL; AK297365; BAG59812.1; ALT_INIT; mRNA.
DR   EMBL; AC093535; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC099513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002515; AAH02515.3; ALT_INIT; mRNA.
DR   EMBL; BC071712; AAH71712.1; ALT_INIT; mRNA.
DR   EMBL; BC073174; AAH73174.1; ALT_INIT; mRNA.
DR   EMBL; AF002696; AAC51935.1; ALT_SEQ; Genomic_DNA.
DR   CCDS; CCDS4137.2; -. [P49419-1]
DR   CCDS; CCDS56380.2; -. [P49419-4]
DR   PIR; A54676; A54676.
DR   RefSeq; NP_001173.2; NM_001182.4. [P49419-1]
DR   RefSeq; NP_001188306.1; NM_001201377.1. [P49419-2]
DR   RefSeq; NP_001189333.2; NM_001202404.1. [P49419-4]
DR   UniGene; Hs.483239; -.
DR   PDB; 2J6L; X-ray; 1.30 A; A/B/C/D/E/F/G/H=30-527.
DR   PDB; 4X0T; X-ray; 2.40 A; A/B/C/D=29-539.
DR   PDB; 4X0U; X-ray; 1.95 A; A/B/C/D=29-539.
DR   PDB; 4ZUK; X-ray; 2.00 A; A/B/C/D/E/F/G/H=29-539.
DR   PDB; 4ZUL; X-ray; 1.76 A; A/B/C/D/E/F/G/H=29-539.
DR   PDB; 4ZVW; X-ray; 2.40 A; A/B/C/D/E/F/G/H=29-539.
DR   PDB; 4ZVX; X-ray; 1.90 A; A/B=29-539.
DR   PDB; 4ZVY; X-ray; 1.90 A; A/B=29-539.
DR   PDBsum; 2J6L; -.
DR   PDBsum; 4X0T; -.
DR   PDBsum; 4X0U; -.
DR   PDBsum; 4ZUK; -.
DR   PDBsum; 4ZUL; -.
DR   PDBsum; 4ZVW; -.
DR   PDBsum; 4ZVX; -.
DR   PDBsum; 4ZVY; -.
DR   ProteinModelPortal; P49419; -.
DR   SMR; P49419; -.
DR   BioGrid; 106990; 37.
DR   IntAct; P49419; 13.
DR   MINT; MINT-1421491; -.
DR   STRING; 9606.ENSP00000387123; -.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; P49419; -.
DR   PhosphoSitePlus; P49419; -.
DR   SwissPalm; P49419; -.
DR   BioMuta; ALDH7A1; -.
DR   DMDM; 294862544; -.
DR   UCD-2DPAGE; P49419; -.
DR   EPD; P49419; -.
DR   MaxQB; P49419; -.
DR   PaxDb; P49419; -.
DR   PeptideAtlas; P49419; -.
DR   PRIDE; P49419; -.
DR   DNASU; 501; -.
DR   Ensembl; ENST00000409134; ENSP00000387123; ENSG00000164904. [P49419-1]
DR   Ensembl; ENST00000553117; ENSP00000448593; ENSG00000164904. [P49419-4]
DR   GeneID; 501; -.
DR   KEGG; hsa:501; -.
DR   UCSC; uc003ktx.5; human. [P49419-1]
DR   CTD; 501; -.
DR   DisGeNET; 501; -.
DR   GeneCards; ALDH7A1; -.
DR   GeneReviews; ALDH7A1; -.
DR   HGNC; HGNC:877; ALDH7A1.
DR   HPA; HPA023296; -.
DR   MalaCards; ALDH7A1; -.
DR   MIM; 107323; gene.
DR   MIM; 266100; phenotype.
DR   neXtProt; NX_P49419; -.
DR   OpenTargets; ENSG00000164904; -.
DR   Orphanet; 3006; Pyridoxine-dependent epilepsy.
DR   PharmGKB; PA24704; -.
DR   eggNOG; KOG2453; Eukaryota.
DR   eggNOG; COG1012; LUCA.
DR   GeneTree; ENSGT00760000118999; -.
DR   HOGENOM; HOG000271511; -.
DR   HOVERGEN; HBG050485; -.
DR   InParanoid; P49419; -.
DR   KO; K14085; -.
DR   OMA; EGYESGC; -.
DR   OrthoDB; EOG091G058Y; -.
DR   PhylomeDB; P49419; -.
DR   TreeFam; TF300388; -.
DR   BioCyc; MetaCyc:HS09157-MONOMER; -.
DR   BRENDA; 1.2.1.31; 2681.
DR   Reactome; R-HSA-6798163; Choline catabolism.
DR   Reactome; R-HSA-71064; Lysine catabolism.
DR   SABIO-RK; P49419; -.
DR   UniPathway; UPA00529; UER00386.
DR   ChiTaRS; ALDH7A1; human.
DR   EvolutionaryTrace; P49419; -.
DR   GeneWiki; ALDH7A1; -.
DR   GenomeRNAi; 501; -.
DR   PRO; PR:P49419; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164904; -.
DR   CleanEx; HS_ALDH7A1; -.
DR   ExpressionAtlas; P49419; baseline and differential.
DR   Genevisible; P49419; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0004029; F:aldehyde dehydrogenase (NAD) activity; ISS:UniProtKB.
DR   GO; GO:0008802; F:betaine-aldehyde dehydrogenase activity; TAS:Reactome.
DR   GO; GO:0004043; F:L-aminoadipate-semialdehyde dehydrogenase activity; EXP:Reactome.
DR   GO; GO:0006081; P:cellular aldehyde metabolic process; ISS:UniProtKB.
DR   GO; GO:0042426; P:choline catabolic process; TAS:Reactome.
DR   GO; GO:0019285; P:glycine betaine biosynthetic process from choline; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006554; P:lysine catabolic process; TAS:Reactome.
DR   GO; GO:0007605; P:sensory perception of sound; TAS:ProtInc.
DR   Gene3D; 3.40.605.10; -; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; SSF53720; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Disease mutation; Epilepsy; Mitochondrion; NAD; Nucleus;
KW   Oxidoreductase; Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     26       Mitochondrion. {ECO:0000255}.
FT   CHAIN        27    539       Alpha-aminoadipic semialdehyde
FT                                dehydrogenase.
FT                                /FTId=PRO_0000056490.
FT   NP_BIND     274    279       NAD. {ECO:0000250}.
FT   ACT_SITE    296    296       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10007}.
FT   ACT_SITE    330    330       Nucleophile.
FT   SITE        195    195       Transition state stabilizer.
FT                                {ECO:0000250}.
FT   MOD_RES      94     94       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBF1}.
FT   MOD_RES      94     94       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBF1}.
FT   MOD_RES     462    462       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBF1}.
FT   MOD_RES     500    500       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBF1}.
FT   MOD_RES     537    537       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBF1}.
FT   VAR_SEQ       1     28       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:8088832}.
FT                                /FTId=VSP_038987.
FT   VAR_SEQ     337    400       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045905.
FT   VARIANT     199    199       A -> V (in PDE; dbSNP:rs121912709).
FT                                {ECO:0000269|PubMed:16491085}.
FT                                /FTId=VAR_031718.
FT   VARIANT     202    202       G -> V (in PDE).
FT                                {ECO:0000269|PubMed:17068770}.
FT                                /FTId=VAR_069184.
FT   VARIANT     291    291       G -> E (in PDE).
FT                                {ECO:0000269|PubMed:17068770}.
FT                                /FTId=VAR_069185.
FT   VARIANT     301    301       N -> I (in PDE; dbSNP:rs121912711).
FT                                {ECO:0000269|PubMed:17068770}.
FT                                /FTId=VAR_069186.
FT   VARIANT     335    335       R -> Q (in PDE; dbSNP:rs754449549).
FT                                {ECO:0000269|PubMed:17068770}.
FT                                /FTId=VAR_069187.
FT   VARIANT     395    395       V -> G (in PDE).
FT                                {ECO:0000269|PubMed:17068770}.
FT                                /FTId=VAR_069188.
FT   VARIANT     412    412       T -> A (in dbSNP:rs2306618).
FT                                /FTId=VAR_028202.
FT   VARIANT     427    427       E -> Q (in PDE; dbSNP:rs121912707).
FT                                {ECO:0000269|PubMed:16491085,
FT                                ECO:0000269|PubMed:17068770}.
FT                                /FTId=VAR_031719.
FT   VARIANT     439    439       K -> Q (in dbSNP:rs12514417).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_028203.
FT   VARIANT     458    458       S -> N (in PDE).
FT                                {ECO:0000269|PubMed:17068770}.
FT                                /FTId=VAR_069189.
FT   CONFLICT    236    236       K -> R (in Ref. 2; BAG59812).
FT                                {ECO:0000305}.
FT   HELIX        33     35       {ECO:0000244|PDB:2J6L}.
FT   HELIX        37     45       {ECO:0000244|PDB:2J6L}.
FT   STRAND       49     52       {ECO:0000244|PDB:2J6L}.
FT   STRAND       54     60       {ECO:0000244|PDB:2J6L}.
FT   STRAND       65     69       {ECO:0000244|PDB:2J6L}.
FT   TURN         71     73       {ECO:0000244|PDB:2J6L}.
FT   STRAND       76     81       {ECO:0000244|PDB:2J6L}.
FT   HELIX        85    102       {ECO:0000244|PDB:2J6L}.
FT   HELIX       107    123       {ECO:0000244|PDB:2J6L}.
FT   HELIX       125    135       {ECO:0000244|PDB:2J6L}.
FT   HELIX       140    160       {ECO:0000244|PDB:2J6L}.
FT   TURN        161    163       {ECO:0000244|PDB:2J6L}.
FT   STRAND      167    169       {ECO:0000244|PDB:2J6L}.
FT   STRAND      176    184       {ECO:0000244|PDB:2J6L}.
FT   STRAND      186    191       {ECO:0000244|PDB:2J6L}.
FT   STRAND      194    196       {ECO:0000244|PDB:2J6L}.
FT   HELIX       199    210       {ECO:0000244|PDB:2J6L}.
FT   STRAND      214    218       {ECO:0000244|PDB:2J6L}.
FT   HELIX       221    223       {ECO:0000244|PDB:2J6L}.
FT   HELIX       224    240       {ECO:0000244|PDB:2J6L}.
FT   HELIX       245    247       {ECO:0000244|PDB:2J6L}.
FT   STRAND      248    251       {ECO:0000244|PDB:2J6L}.
FT   HELIX       255    263       {ECO:0000244|PDB:2J6L}.
FT   STRAND      268    274       {ECO:0000244|PDB:2J6L}.
FT   HELIX       276    288       {ECO:0000244|PDB:2J6L}.
FT   STRAND      292    296       {ECO:0000244|PDB:2J6L}.
FT   STRAND      301    305       {ECO:0000244|PDB:2J6L}.
FT   HELIX       311    323       {ECO:0000244|PDB:2J6L}.
FT   HELIX       324    327       {ECO:0000244|PDB:2J6L}.
FT   STRAND      333    339       {ECO:0000244|PDB:2J6L}.
FT   TURN        340    342       {ECO:0000244|PDB:2J6L}.
FT   HELIX       343    355       {ECO:0000244|PDB:2J6L}.
FT   HELIX       375    390       {ECO:0000244|PDB:2J6L}.
FT   STRAND      394    397       {ECO:0000244|PDB:2J6L}.
FT   STRAND      403    407       {ECO:0000244|PDB:2J6L}.
FT   STRAND      412    416       {ECO:0000244|PDB:2J6L}.
FT   HELIX       422    425       {ECO:0000244|PDB:2J6L}.
FT   STRAND      429    438       {ECO:0000244|PDB:2J6L}.
FT   HELIX       441    449       {ECO:0000244|PDB:2J6L}.
FT   STRAND      451    453       {ECO:0000244|PDB:4X0U}.
FT   STRAND      455    460       {ECO:0000244|PDB:2J6L}.
FT   HELIX       464    471       {ECO:0000244|PDB:2J6L}.
FT   STRAND      478    485       {ECO:0000244|PDB:2J6L}.
FT   STRAND      494    496       {ECO:0000244|PDB:2J6L}.
FT   HELIX       500    502       {ECO:0000244|PDB:2J6L}.
FT   TURN        504    506       {ECO:0000244|PDB:4X0U}.
FT   STRAND      507    509       {ECO:0000244|PDB:2J6L}.
FT   HELIX       512    516       {ECO:0000244|PDB:2J6L}.
FT   STRAND      517    525       {ECO:0000244|PDB:2J6L}.
FT   HELIX       533    535       {ECO:0000244|PDB:4ZUL}.
SQ   SEQUENCE   539 AA;  58487 MW;  05385562F71312B6 CRC64;
     MWRLPRALCV HAAKTSKLSG PWSRPAAFMS TLLINQPQYA WLKELGLREE NEGVYNGSWG
     GRGEVITTYC PANNEPIARV RQASVADYEE TVKKAREAWK IWADIPAPKR GEIVRQIGDA
     LREKIQVLGS LVSLEMGKIL VEGVGEVQEY VDICDYAVGL SRMIGGPILP SERSGHALIE
     QWNPVGLVGI ITAFNFPVAV YGWNNAIAMI CGNVCLWKGA PTTSLISVAV TKIIAKVLED
     NKLPGAICSL TCGGADIGTA MAKDERVNLL SFTGSTQVGK QVGLMVQERF GRSLLELGGN
     NAIIAFEDAD LSLVVPSALF AAVGTAGQRC TTARRLFIHE SIHDEVVNRL KKAYAQIRVG
     NPWDPNVLYG PLHTKQAVSM FLGAVEEAKK EGGTVVYGGK VMDRPGNYVE PTIVTGLGHD
     ASIAHTETFA PILYVFKFKN EEEVFAWNNE VKQGLSSSIF TKDLGRIFRW LGPKGSDCGI
     VNVNIPTSGA EIGGAFGGEK HTGGGRESGS DAWKQYMRRS TCTINYSKDL PLAQGIKFQ
//
